Stockreport

Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder

Cybin Inc. Common Shares  (CYBN) 
PDF - Anxiety disorders are the most prevalent mental health disorders globally1, contributing to over 28 million disability-adjusted life years (“DALYs”)2 -- Highly scalabl [Read more]